OK, I am looking into the new Midlines by Bard; Power Glides, telling my Critical Care Dr ( my PICC line MD resource) about the midlines and how they are shorter,
but can stay long and have less of the risks versus central lines; like decrease DVT and CRBSI, he says "no they dont", he feels they have the same risk for DVT, and infection.
I do realize the differences in what they can be used for, and I do see a moderate size population that I think they may be appropriate for.
Any studies out there you are aware of that have looked at these issues.?